REQUEST A DEMO
Total
USD $0.00
Search more companies

Texas Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Texas Pharmaceuticals Private Limited Profile Updated: January 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Texas Pharmaceuticals Private Limited is an unlisted company, incorporated on 19/07/2011. It has its registered office in the State of Haryana, India. Company's corporate identification number (CIN) is U24232HR2011PTC043450 and registration number is 043450. The company is a manufacturing company, it is engaged in manufacture of pharmaceuticals, medicinal chemical and botanical products.

Legal Address
#87, Basement, Dayal Singh Colony, Karnal
Karnal; Haryana; Postal Code: 132001

Contact Details: Purchase the Texas Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Texas Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Texas Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
July 19, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Texas Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
3.22%
Total operating revenue
3.22%
Operating profit (EBIT)
80.08%
EBITDA
55.9%
Net Profit (Loss) for the Period
14.58%
Total Assets
21.93%
Total Equity
4.19%
Operating Profit Margin (ROS)
0.88%
Net Profit Margin
0.06%
Return on Equity (ROE)
0.35%
Debt/Equity
5.35%
Quick Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?